Product Overview
Cagrilintide 5mg is a long-acting, synthetic amylin analogue specifically developed for advanced metabolic and endocrine research. As a non-selective agonist of amylin receptors and a potent modulator of satiety, Cagrilintide is a primary tool for studying appetite regulation, gastric emptying dynamics, and body composition in experimental models.
Supplied in a 5mg lyophilized powder format, this research-grade peptide is engineered for high stability and consistent results. Cagrilintide is most frequently investigated for its synergistic effects when studied alongside GLP-1 receptor agonists (such as Semaglutide).
Mechanism of Action: Satiety & Appetite Regulation
Cagrilintide mimics the naturally occurring hormone amylin, which is co-secreted with insulin by the pancreas. In laboratory research models, its primary mechanisms include:
- Satiety Elevation: Acts on the brain’s appetite-regulating centers to suppress hunger signals and reduce cravings.
- Gastric Emptying Modulation: Slows the rate of gastric emptying, leading to a prolonged sense of fullness after meals.
- Dual-Agonism Potential: When used in combination therapy research, Cagrilintide enhances the satiety signals of GLP-1 peptides, often leading to superior metabolic outcomes compared to monotherapy.
Primary Research Applications & Benefits
- Advanced Weight Management Research
In clinical research models, the combination of Cagrilintide and Semaglutide has shown a synergistic effect. Studies have observed significant weight loss—often exceeding 20% of total body weight—comparable to the outcomes of bariatric surgery. - Glycemic & Insulin Resistance Studies Cagrilintide is a critical tool for researchers investigating blood sugar regulation. Studies suggest potential for reversing prediabetic markers and improving insulin sensitivity in metabolic models.
- Cardiometabolic Health Biomarkers Research involving Cagrilintide extends to broader health metrics, including: • Reductions in blood pressure. • Improvements in lipid profiles (cholesterol and triglycerides). • Decreased systemic inflammatory markers.
- Pharmacokinetics & Once-Weekly Dosing Unlike early amylin analogues, Cagrilintide is engineered for a long half-life. In research settings, this allows for a once-weekly dosing schedule, providing more stable compound levels and higher protocol adherence in longitudinal studies.
Storage & Reconstitution Guidelines
- Long-term Storage: Store unopened vials in a freezer at -20°C.
- Short-term Storage: Refrigerate at 2°C–8°C for immediate research use.
- Reconstitution: Reconstitute with bacteriostatic water. Once dissolved, keep the solution refrigerated and use within 21 days for optimal research potency.
Reviews
There are no reviews yet.